Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TNAV
4826
DELISTED
Telenav Inc.
TNAV
| $119K | ﹤0.01% |
29,297
+17,592
| +150% | +$75.7K |
|
|
ATHN
4827
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $119K | ﹤0.01% |
900
-15,100
| -94% | -$1.93M |
|
4828
PUT
Cemex
CX
$16.2B
| $118K | ﹤0.01% |
24,400
-3,000
| -11% | -$16K |
|
|
CBIO
4829
Crescent Biopharma
CBIO
$610M
| $118K | ﹤0.01% |
124
-143
| -54% | -$172K |
|
4830
Kornit Digital
KRNT
$819M
| $118K | ﹤0.01% |
6,333
-558,553
| -99% | -$10.9M |
|
4831
PUT
Manulife Financial
MFC
$73B
| $118K | ﹤0.01% |
8,300
+7,900
| +1,975% | +$125K |
|
4832
Westlake Chemical Partners
WLKP
$777M
| $118K | ﹤0.01% |
4,885
-2,743
| -36% | -$63.3K |
|
|
GPP
4833
DELISTED
Green Plains Partners LP
GPP
| $118K | ﹤0.01% |
+8,702
| New | +$126K |
|
|
NVTR
4834
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $118K | ﹤0.01% |
7,246
-34,311
| -83% | -$656K |
|
4835
Marriott Vacations Worldwide
VAC
$4.01B
| $117K | ﹤0.01% |
1,665
-33,831
| -95% | -$2.82M |
|
4836
PUT
Aramark
ARMK
$16B
| $116K | ﹤0.01% |
+5,540
| New | +$144K |
|
4837
Global Partners
GLP
$1.73B
| $116K | ﹤0.01% |
+7,102
| New | +$127K |
|
4838
Oragenics
OGEN
$2.42M
| $116K | ﹤0.01% |
75
+37
| +97% | +$72.5K |
|
4839
PUT
RCI Hospitality Holdings
RICK
$207M
| $116K | ﹤0.01% |
5,200
+4,900
| +1,633% | +$123K |
|
|
LTHM
4840
DELISTED
Livent Corporation
LTHM
| $116K | ﹤0.01% |
+8,477
| New | +$138K |
|
|
CONE
4841
PUT
DELISTED
CyrusOne Inc Common Stock
CONE
| $116K | ﹤0.01% |
+2,200
| New | +$126K |
|
4842
PUT
BioCryst Pharmaceuticals
BCRX
$2.62B
| $115K | ﹤0.01% |
14,300
-6,400
| -31% | -$49.8K |
|
|
BPT
4843
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $115K | ﹤0.01% |
5,313
+5,312
| +531,200% | +$153K |
|
4844
PUT
Credit Acceptance
CACC
$5.88B
| $115K | ﹤0.01% |
300
-10,000
| -97% | -$4.03M |
|
4845
Digi International
DGII
$3.23B
| $115K | ﹤0.01% |
11,414
-18,394
| -62% | -$213K |
|
4846
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $115K | ﹤0.01% |
3,475
| – | – |
|
4847
Quad
QUAD
$502M
| $115K | ﹤0.01% |
9,419
-33,186
| -78% | -$535K |
|
4848
CALL
Safety Insurance
SAFT
$1.52B
| $115K | ﹤0.01% |
1,400
| – | – |
|
4849
Titan International
TWI
$449M
| $115K | ﹤0.01% |
24,829
-29,002
| -54% | -$188K |
|
|
VER
4850
CALL
DELISTED
VEREIT, Inc.
VER
| $115K | ﹤0.01% |
3,220
+1,760
| +121% | +$65.3K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.